Opioid and sigma receptor studies. New developments in the design of selective sigma ligands

Articles in the same Issue

1. Molecular recognition at kappa opioid receptors
2. Semicarbazide-sensitive amine oxidase. Its physiological significance
3. Chemical development of the vasopressin receptor 2 antagonist SR-121463
4. New developments in A1 and A2 adenosine receptor antagonists
5. Antitumor acridines with diaminoalkylo pharmacophoric group
6. NMR spectroscopy in drug design
7. Retinoic acid and analogs as potent inducers of differentiation and apoptosis. New promising chemopreventive and chemotherapeutic agents in oncology
8. New chemical structures of hypolipidemic and antiplatelet activity
9. New small-molecule tubulin inhibitors
10. Gradient HPLC in the determination of drug lipophilicity and acidity
11. Rational design and synthesis of homochiral azole antifungal agents
12. Combinatorial chemistry. Facing the challenge of chemical genomics
13. Opioid and sigma receptor studies. New developments in the design of selective sigma ligands
14. Generic source-based nomenclature for polymers(IUPAC Recommendations 2001)
15. Quantum chemical B3LYP/cc-pvqz computation of ground-state structures and properties of small molecules with atoms of Z ≤ 18 (hydrogen to argon)(IUPAC Technical Report)